{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:29:15Z","timestamp":1794324555697,"version":"4.9.0"},"reference-count":81,"publisher":"ScopeMed","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.scopemed.org\/?page=license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.5455\/medarh.2018.72.303-305","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T19:17:45Z","timestamp":1533669465000},"source":"Crossref","is-referenced-by-count":3,"title":["Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine"],"prefix":"10.5455","member":"3407","reference":[{"key":"ref1","unstructured":"1. DailyMed \u2013 OXCARBAZEPINE\u2013oxcarbazepine tablet [Inter -"},{"key":"ref2","unstructured":"net]. Dailymed.nlm.nih.gov. 2018 [cited 24 May 2018]. Avail -"},{"key":"ref3","unstructured":"able from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo."},{"key":"ref4","unstructured":"cfm?setid=17325a80-fb9c-4a83-b4b4-98e0b999d852."},{"key":"ref5","unstructured":"2. Glauser T. Oxcarbazepine in the Treatment of Epilepsy. Phar -"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"macotherapy. 2001; 21(8): 904-919.","DOI":"10.1592\/phco.21.11.904.34513"},{"key":"ref7","unstructured":"3. Zhou M, Chen N, He L, Yang M, Zhu C, Wu F. Oxcarbaze -"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"pine for neuropathic pain. Cochrane Database Syst Rev. 2017;","DOI":"10.1002\/14651858.CD007963.pub3"},{"key":"ref9","unstructured":"(12): CD007963."},{"key":"ref10","unstructured":"4. Ghaemi S, Berv D, Klugman J, Rosenquist K, Hsu D. Oxcar -"},{"key":"ref11","unstructured":"bazepine Treatment of Bipolar Disorder. J Clin Psychiatry."},{"key":"ref12","unstructured":"2003; 64(8): 943-945."},{"key":"ref13","unstructured":"5. Hirschfeld R, Kasper S. A review of the evidence for carbamaz -"},{"key":"ref14","unstructured":"epine and oxcarbazepine in the treatment of bipolar disorder."},{"key":"ref15","unstructured":"Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine"},{"key":"ref16","unstructured":"305 CASE REPORT | MED ARCH. 2018 AUG; 72(4): 303-305Int J Neuropsychopharmacol. 2004; 7(4): 507-522."},{"key":"ref17","unstructured":"6. Buggy Y, Layton D, Fogg C, Shakir S. Safety profile of oxcar -"},{"key":"ref18","unstructured":"bazepine: Results from a prescription-event monitoring study."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Epilepsia. 2010; 51(5): 818-829.","DOI":"10.1111\/j.1528-1167.2009.02489.x"},{"key":"ref20","unstructured":"7. Berghuis B, van der Palen J, de Haan G, Lindhout D, Koe -"},{"key":"ref21","unstructured":"leman B, Sander J. Carbamazepine- and oxcarbazepine-in -"},{"key":"ref22","unstructured":"duced hyponatremia in people with epilepsy. Epilepsia. 2017;"},{"key":"ref23","unstructured":"58(7): 1227-1233."},{"key":"ref24","unstructured":"8. Spiller H, Strauch J, Essing-Spiller S, Burns G. Thirteen years"},{"key":"ref25","unstructured":"of oxcarbazepine exposures reported to US poison centers."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Hum Exp Toxicol. 2016; 35(10):1055-1059.","DOI":"10.1177\/0960327115618246"},{"key":"ref27","unstructured":"9. Shrestha G, Keyal N, Pradhan S, Maharjan R, Acharya S, Mar -"},{"key":"ref28","unstructured":"hatta M. Olanzapine overdose presenting with acute muscle"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"toxicity. Int J Crit Illn Inj Sci. 2017; 7(1): 69.","DOI":"10.4103\/2229-5151.201962"},{"key":"ref30","unstructured":"10. DailyMed \u2013 OLANZAPINE\u2013olanzapine tablet, film coated"},{"key":"ref31","unstructured":"[Internet]. Dailymed.nlm.nih.gov. 2018 [cited 24 May 2018]."},{"key":"ref32","unstructured":"Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/dru -"},{"key":"ref33","unstructured":"gInfo.cfm?setid=676ace4e-7706-742d-cab0-430dd1f83408."},{"key":"ref34","unstructured":"11. Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid"},{"key":"ref35","unstructured":"F, Kissling W et al. Second-Generation Antipsychotic Drugs"},{"key":"ref36","unstructured":"and Extrapyramidal Side Effects: A Systematic Review and"},{"key":"ref37","unstructured":"Meta-analysis of Head-to-Head Comparisons. Schizophr Bull."},{"key":"ref38","unstructured":"2010; 38(1): 167-177."},{"key":"ref39","unstructured":"12. Albaugh V, Singareddy R, Mauger D, Lynch C. A Double"},{"key":"ref40","unstructured":"Blind, Placebo-Controlled, Randomized Crossover Study of"},{"key":"ref41","unstructured":"the Acute Metabolic Effects of Olanzapine in Healthy Volun -"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"teers. PLoS ONE. 2011; 6(8): e22662.","DOI":"10.1371\/journal.pone.0022662"},{"key":"ref43","unstructured":"13. Chue P, Singer P. A review of olanzapine-associated toxicity"},{"key":"ref44","unstructured":"and fatality in overdose. J Psychiatry Neurosci. 2003; 28(4):"},{"key":"ref45","unstructured":"14. Ciszowski K, Sein Anand J. [Electrocardiographic abnormal -"},{"key":"ref46","unstructured":"ities in acute olanzapine poisonings]. Przegl Lek. 2011; 68(8):"},{"key":"ref47","unstructured":"15. May T, Korn-Merker E, Rambeck B. Clinical Pharmacokinet -"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"ics of Oxcarbazepine. Clin Pharmacokinet. 2003; 42(12):1023-1042.","DOI":"10.2165\/00003088-200342120-00002"},{"key":"ref49","unstructured":"16. Ker\u00e4nen T, Sorri A, Moilanen E, Ylitalo P. Effects of charcoal"},{"key":"ref50","unstructured":"on the absorption and elimination of the antiepileptic drugs"},{"key":"ref51","unstructured":"lamotrigine and oxcarbazepine. Arzneimittelforschung. 2011;"},{"key":"ref52","unstructured":"60(07): 421-426."},{"key":"ref53","unstructured":"17. Rosaria Muscatello M, Pacetti M, Cacciola M, La Torre D,"},{"key":"ref54","unstructured":"Zoccali R, Arrigo C et al. Plasma Concentrations of Risperi -"},{"key":"ref55","unstructured":"done and Olanzapine during Coadministration with Oxcar -"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"bazepine. Epilepsia. 2005; 46(5): 771-774.","DOI":"10.1111\/j.1528-1167.2005.71104.x"},{"key":"ref57","unstructured":"18. Littlewood R, Claus E, Arenella P, Bogenschutz M, Karoly H,"},{"key":"ref58","unstructured":"Ewing S et al. Dose specific effects of olanzapine in the treat -"},{"key":"ref59","unstructured":"ment of alcohol dependence. Psychopharmacology (Berl). 2014;"},{"key":"ref60","unstructured":"232(7): 1261-1268."},{"key":"ref61","unstructured":"19. Barrons R, Roberts N. The role of carbamazepine and oxcar -"},{"key":"ref62","unstructured":"bazepine in alcohol withdrawal syndrome. J Clin Pharm Ther."},{"key":"ref63","unstructured":"2009; 35(2): 153-167."},{"key":"ref64","unstructured":"20. Pani P, Trogu E, Pacini M, Maremmani I. Anticonvulsants"},{"key":"ref65","unstructured":"for alcohol dependence. Cochrane Database Syst Rev. 2014;"},{"key":"ref66","unstructured":"(2): CD008544."},{"key":"ref67","unstructured":"21. Hutchison K, Wooden A, Swift R, Smolen A, McGeary J, Ad -"},{"key":"ref68","unstructured":"ler L et al. Olanzapine Reduces Craving for Alcohol: A DRD4"},{"key":"ref69","unstructured":"VNTR Polymorphism by Pharmacotherapy Interaction. Neu -"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"ropsychopharmacology. 2003; 28(10): 1882-1888.","DOI":"10.1038\/sj.npp.1300264"},{"key":"ref71","unstructured":"22. Ciszowski K, Sein Anand J, Wilimowska J, Jawie\u0144 W. [The"},{"key":"ref72","unstructured":"clinical picture of acute olanzapine poisonings]. Przegl Lek."},{"key":"ref73","unstructured":"2011; 68(8): 426-433."},{"key":"ref74","unstructured":"23. Palenzona S, Meier P, Kupferschmidt H, Rauber\u2010Luethy C."},{"key":"ref75","unstructured":"The Clinical Picture of Olanzapine Poisoning with Special"},{"key":"ref76","unstructured":"Reference to Fluctuating Mental Status. J Toxicol Clin Toxi -"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"col. 2004; 42(1): 27-32.","DOI":"10.54648\/TAXI2004003"},{"key":"ref78","unstructured":"24. Wills B, Reynolds P, Chu E, Murphy C, Cumpston K, Strom -"},{"key":"ref79","unstructured":"berg P et al. Clinical Outcomes in Newer Anticonvulsant"},{"key":"ref80","unstructured":"Overdose: A Poison Center Observational Study. J Med Tox -"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"icol. 2014; 10(3): 254-260.","DOI":"10.1080\/17449626.2014.965392"}],"container-title":["Medical Archives"],"original-title":[],"link":[{"URL":"https:\/\/ejmanager.com\/mnstemps\/10\/10-1533474070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:55:57Z","timestamp":1791482157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejmanager.com\/mnstemps\/10\/10-1533474070.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":81,"URL":"https:\/\/doi.org\/10.5455\/medarh.2018.72.303-305","relation":{},"ISSN":["0350-199X"],"issn-type":[{"value":"0350-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}